Affiliation: Pfizer Inc.

Dr. Lyndsey Meyer is a Quantitative Systems Pharmacologist at Pfizer supporting the Internal Medicine Research Unit. Dr. Meyer graduated from Binghamton University with a BS in Biochemistry before obtaining her PhD in Pharmaceutical Sciences from the University at Buffalo under the guidance of Dr. Dhaval Shah. At Buffalo, her thesis focused on understanding the weight loss mechanism with oxidative phosphorylation uncouplers for treating obesity. Since graduating in 2019, she has joined the Quantitative Systems Pharmacology group at Pfizer, where she works in metabolic diseases, including non-alcoholic fatty liver disease (NAFLD), cachexia, obesity, and heart failure.